Melanoma in Practice: Nurse Conference

Melanoma in Practice: Nurse Conference

26 July 2018

It was a full house this week at Melanoma Institute Australia thanks to our ‘Melanoma in Practice: Nurse Conference’.  Designed specifically for nurses, the presentations were designed to give nurses a better understanding of the patient experience from detection through to treatment of advanced disease and included updates in the latest areas of research that are changing the way we treat melanoma.

Presentations were given by melanoma specialists in dermatology, pathology, medical oncology, surgery, radiotherapy, physiotherapy, psychology and clinical trials, as well as melanoma survivors and CNCs who are directly involved in melanoma care

Highlights included a presentation from Associate Professor Robyn Saw who discussed the processes of surgical management of melanoma Stages 0-IV and how “understanding the anatomy is essential for diagnosing and treating melanoma”. 

A key takeaway from the conference was a presentation by Associate Professor Matteo Carlino. Associate Professor Carlino delved into the system therapy for the treatment of advanced melanoma and notably pointed out how there has been a shift in nurses’ role in melanoma.  “It used to be that advanced melanoma nurses worked primarily on palliative care. We're now in a time where nurses are working on survivorship care”, said Associate Professor Carlino, a statement that really resonated with the audience.

We’d like to thank those who attended and engaged with the conference. One attendee said that ‘all the sessions were so informative and the presenters had a real passion for their work’ and we hope that all attendees found it both enjoyable and beneficial.

The presentations from the Nurse Conference will be made available on our free melanoma education portal for healthcare practitioners in the next few weeks.  If you’re a nurse, we encourage you to register your interest at www.melanomaeducation.org.au to be the first to know when they become available.

The Federal Government's 2015-16 Budget announcements benefit research
14 May 2015

The Federal Government's 2015-16 Budget announcements benefit research

The Federal Government’s 2015-16 Budget was announced this week with a boost for medical research funding. 

Professor Thompson made an honorary member of the American Surgical Association
01 May 2015

Professor Thompson made an honorary member of the American Surgical Association

The Association's members include prominent surgeons from around the world. 

MIA leads the world-first study that finds anti–PD-1 antibody pembrolizumab increases the survival of patients
20 Apr 2015

MIA leads the world-first study that finds anti–PD-1 antibody pembrolizumab increases the survival of patients

This is a landmark study, the first in a class of drugs that will change the future of treatment for all cancers. 

Anti-PD1 immunotherapy pembrolizumab (KEYTRUDA®) has been registered by the TGA
20 Apr 2015

Anti-PD1 immunotherapy pembrolizumab (KEYTRUDA® ) has been registered by the TGA

Australia is the first country in the world to register anti-PD1 for the first line treatment of unresectable or metastatic melanoma in adults.

MIA's Autumn Newsletter
12 Apr 2015

MIA's Autumn Newsletter

Our Autumn newsletter has been published and we have our digital version online now. 

Professor John Thompson appointed to Australian Academy of Health and Medical Sciences
31 Mar 2015

Professor John Thompson appointed to Australian Academy of Health and Medical Sciences

Professor John Thompson, Executive Director at Melanoma Institute Australia, was one of 116 fellows appointed to the new Australian Academy of Health and Medical Sciences at a ceremony in Canberra on the 25th March.

Melanoma Institute part of $14m melanoma project grant
25 Mar 2015

Melanoma Institute part of $14m melanoma project grant

Federal Minister for Health, the Hon. Sussan Ley, announced more than $14 million in funding for a research program to study the molecular determinants of risk, progression and treatment response in melanoma.

Melanoma March Bibs
19 Mar 2015

Melanoma March Bibs

If you would like to download a bib for your Melanoma March, we have a selection for you to choose from, print and bring along with you on the day. 

Manly Melanoma March
17 Mar 2015

Manly Melanoma March

Manly Melanoma March has changed to a new location. 

Q&A with Melanoma March Fundraisers
10 Mar 2015

Q&A with Melanoma March Fundraisers

We did a short Q&A with two sisters who are raising funds for Melanoma March after sadly losing their mother in 2009. This is their second march and they have shared with us their fundraising tips. 

Research Director Graham Mann explains where Melanoma March funds are going
10 Mar 2015

Research Director Graham Mann explains where Melanoma March funds are going

We want to share with you what your valuable Melanoma March donation and fundraising goes towards and our Research Director, Graham Mann explains the national research project the funds will be going towards.

First patient recruited to the EAGLE FM Trial
09 Mar 2015

First patient recruited to the EAGLE FM Trial

Evaluation of Groin Lymphadenectomy Extent for Metastatic Melanoma (EAGLE FM) clinical trial has recruited its first patient.  

Online Comments to the Pharmaceutical Benefits Advisory Committee
09 Feb 2015

Online Comments to the Pharmaceutical Benefits Advisory Committee

You are invited to provide comments for consideration by the Pharmaceutical Benefits Advisory Committee (PBAC). The PBAC will consider the registration of the anti-PD1 drug, Keytruda (pembrolizumab) at the next meeting in March.

A man of commitment
06 Feb 2015

A man of commitment

Melanoma patient Joel Allsop was congratulated today on completing his participation in the international surgical clinical trial, known as MSLT-II. He was the first person in the world to complete the 10 years of follow-up for this trial. 

Melanoma March has officially launched
05 Feb 2015

Melanoma March has officially launched

Melanoma Institute Australia (MIA) has officially launched the 2015 ‘Melanoma March’ initiative in Melbourne. 

Melanoma March is around the corner
02 Feb 2015

Melanoma March is around the corner

Help us march towards a cure for melanoma research. See where your local march is and how you can get involved.

Q&A with a PhD student
28 Jan 2015

Q&A with a PhD student

Under the leadership of world-leading melanoma pathologist Prof Richard Scolyer and medical oncologist A/Prof Georgina Long, third year PhD student, Hojabr Kakavand, is at the forefront of melanoma research. 

ClinTrial Refer Melanoma App
22 Jan 2015

ClinTrial Refer Melanoma App

Melanoma Institute Australia has launched a new smartphone app called ClinTrial Refer Melanoma to help busy clinicians find clinical trials for their melanoma patients.

Interview on the latest melanoma treatments
08 Jan 2015

Interview on the latest melanoma treatments

MIA's Associate Professor Georgina Long and stage 4 melanoma patient, Maria, were recently interviewed by ABC Weekend Breakfast about the latest in clincial trials and melanoma treatments.